Cargando…
Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
Purpose: The withdrawal of HVAD in 2021 created a concern for the pediatric population. The alternative implantable centrifugal blood pump HeartMate 3 has since been used more frequently in children. This paper analyses the outcome of children on LVAD support provided with an HVAD or HM3. Methods: A...
Autores principales: | Schweiger, Martin, Hussein, Hina, de By, Theo M. M. H., Zimpfer, Daniel, Sliwka, Joanna, Davies, Ben, Miera, Oliver, Meyns, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455245/ https://www.ncbi.nlm.nih.gov/pubmed/37623364 http://dx.doi.org/10.3390/jcdd10080351 |
Ejemplares similares
-
Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023) -
Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer
por: Butt, Nausharwan, et al.
Publicado: (2023) -
Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020) -
Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery
por: Feldmann, Christina, et al.
Publicado: (2017) -
Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)